
Zim Laboratories Ltd is Rated Sell by MarketsMOJO
2026-11-21 10:10:19Zim Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 November 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read More
Zim Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-11-17 08:02:11Zim Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating. Despite a recent day decline of 1.73%, the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a recalibration of price attractiveness relative to its historical and peer benchmarks.
Read More
Zim Laboratories Ltd is Rated Sell by MarketsMOJO
2026-11-10 10:10:43Zim Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 November 2026, providing investors with the most recent and relevant data to assess the stock’s outlook.
Read More
Zim Laboratories Ltd Reports Mixed Quarterly Results Amid Margin Pressures
2026-11-06 11:01:11Zim Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, reported its September 2026 quarter results reflecting a shift from a previously flat to a negative financial trend. Despite robust net sales growth and record operating cash flow, the company’s profitability and return metrics deteriorated sharply, prompting a downgrade in its Mojo Grade to Sell from Strong Sell as of 5 May 2026.
Read MoreZim Laboratories Gains 7.78%: 4 Key Factors Driving the Weekly Momentum
2026-10-31 14:01:39Key Events This Week 26 Oct: Technical momentum shifts amid mixed indicators; valuation turns attractive 27 Oct: Strong price gains continue, supported by positive volume and moving averages 29 Oct: Bullish momentum shift with 6.3% daily gain amid mixed technical signals 30 Oct: Technical momentum moderates to mildly bullish despite a slight price decline Week OpenRs.126.60 ...
Read More
Zim Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-10-30 08:02:24Zim Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a day decline of 3.63%, the stock’s year-to-date return of 90.08% significantly outpaces the Sensex’s negative 12.99%, signalling underlying strength amid mixed technical signals.
Read More
Zim Laboratories Ltd Sees Bullish Momentum Shift Amid Mixed Technical Signals
2026-10-29 08:02:40Zim Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent performance and technical repositioning suggest a cautiously optimistic outlook for investors.
Read More
Zim Laboratories Ltd is Rated Sell by MarketsMOJO
2026-10-28 10:11:02Zim Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 5 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.
Read More
Zim Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicators
2026-10-26 08:02:33Zim Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a day decline of 3.87% to close at ₹126.60, the stock’s technical indicators present a complex picture, with some signals pointing to strength while others suggest caution. This article analyses the recent technical parameter changes, key momentum indicators, and the implications for investors amid a volatile market backdrop.
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
11-Nov-2026 | Source : BSETranscript of Q2 & H1FY27 Earnings Conference Call
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
05-Nov-2026 | Source : BSEPlease find enclosed the disclosure pertaining to the audio recording of Q2 & H1 FY27 Earnings Conference Call.
Announcement under Regulation 30 (LODR)-Newspaper Publication
05-Nov-2026 | Source : BSEPlease find enclosed the Newspaper Publication of financial results for the Quarter & Half yearly ended 30th September 2026.
Corporate Actions
No Upcoming Board Meetings
Zim Laboratories Ltd has declared 5% dividend, ex-date: 19 Sep 19
No Splits history available
Zim Laboratories Ltd has announced 2:1 bonus issue, ex-date: 22 Dec 22
No Rights history available